Home FDA Panel Backs Inhaler Drug For Lung Disease
 

Keywords :   


FDA Panel Backs Inhaler Drug For Lung Disease

2013-04-18 17:01:14| Biotech - Topix.net

A panel of respiratory experts voted Wednesday in favor of approving an experimental inhaler drug from GlaxoSmithKline and Theravance for treating chronic lung disease.

Tags: panel drug disease lung

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news

»
01.07Hurricane Beryl Graphics
01.07Hurricane Beryl Public Advisory Number 10A
01.07Summary for Hurricane Beryl (AT2/AL022024)
01.07Tropical Storm Chris Graphics
01.07Tropical Storm Chris Public Advisory Number 2A
01.07Atlantic Tropical Weather Outlook
01.07Eastern North Pacific Tropical Weather Outlook
01.07Tropical Storm Chris Update Statement
More »